Abstract: Embodiments are disclosed for a single RGBIR camera module that is capable of imaging at both the visible and IR wavelengths. In some embodiments, a camera module comprises: an image sensor comprising: a microlens array; a color filter array (CFA) comprising a red filter, a blue filter, a green filter and at least one infrared (IR) filter; and a pixel array comprising pixels to convert light received through the color filter array into electrical signals; and an image signal processor (ISP) configured to: initiate capture of a first frame by reading signal pixels from the pixel array; initiate capture of a second frame by reading IR pixels from the pixel array; align the first and second frames; and extract the second frame from the first frame to generate a third enhanced frame.

Abstract: The present invention relates to a method for coating catheter balloons with the pharmacological agent paclitaxel and the biological and biodegradable polymer composition shellac and optionally further components. Moreover the present invention relates to paclitaxel and shellac coated catheter balloons obtained according to the coating methods disclosed herein as well as the use of such coated catheter balloons for the short time release of the pharmaceutically active agent paclitaxel for prophylaxis and treatment of restenosis especially restenosis caused by angioplasty. The coated catheter balloons can be used alone or in combination with a coated or uncoated stent crimped on the catheter balloon before or after the coating with shellac and paclitaxel.

Abstract: The present invention relates to a method for coating catheter balloons with the pharmacological agent paclitaxel and the biological and biodegradable polymer composition shellac and optionally further components. Moreover the present invention relates to paclitaxel and shellac coated catheter balloons obtained according to the coating methods disclosed herein as well as the use of such coated catheter balloons for the short time release of the pharmaceutically active agent paclitaxel for prophylaxis and treatment of restenosis especially restenosis caused by angioplasty. The coated catheter balloons can be used alone or in combination with a coated or uncoated stent crimped on the catheter balloon before or after the coating with shellac and paclitaxel.

Abstract: The present invention relates to processes and apparatuses for producing hydrophobized fiber cement sheets as well as fiber cement sheets obtainable therewith. In particular, the present invention provides processes for manufacturing a hydrophobized fiber cement product, said process at least comprising the steps of: (i) forming at least one fiber cement film on a rotating sieve in contact with a fiber cement slurry in a vat; (ii) transferring said at least one fiber cement film from said sieve to a felt transport belt, (iii) applying a mist of a hydrophobizing agent to said at least one fiber cement film, and (iv) accumulating the fiber cement film on an accumulator roll via the felt transport belt, so as to form a hydrophobized fiber cement product. The present invention further relates to various uses of the fiber cement sheets obtainable by the processes of the invention in the building industry.

Abstract: The present invention relates to a method for coating catheter balloons with the pharmacological agent paclitaxel and the biological and biodegradable polymer composition shellac and optionally further components. Moreover the present invention relates to paclitaxel and shellac coated catheter balloons obtained according to the coating methods disclosed herein as well as the use of such coated catheter balloons for the short time release of the pharmaceutically active agent paclitaxel for prophylaxis and treatment of restenosis especially restenosis caused by angioplasty. The coated catheter balloons can be used alone or in combination with a coated or uncoated stent crimped on the catheter balloon before or after the coating with shellac and paclitaxel.

Abstract: A system for providing account compensation includes an interface and a processor. The interface is configured to receive a set of activity events associated with a user. The processor is configured to: determine a user compensation event from the set of activity events; determine a stakeholder associated with the user compensation event; determine an attention level associated with the user compensation event; determine a value for the user compensation event based at least in part on the stakeholder and the attention level; and provide an indication to compensate an account associated with the user by a compensation amount corresponding to the value.

Abstract: The present invention is directed to catheter balloons and balloon catheters with such catheter balloons coated with at least one layer containing at least one antiproliferative, immunosuppressive, anti-angiogenic, anti-inflammatory, anti-restenotic and/or anti-thrombotic agent and a top coat consisting of a polyvinyl alcohol—polyethylene glycol graft copolymer as well as the use of these balloon catheters for the prevention of restenosis.

Abstract: The present invention relates to processes and apparatuses for producing hydrophobized fiber cement sheets as well as fiber cement sheets obtainable therewith. In particular, the present invention provides processes for manufacturing a hydrophobized fiber cement product, said process at least comprising the steps of: (i) forming at least one fiber cement film on a rotating sieve in contact with a fiber cement slurry in a vat; (ii) transferring said at least one fiber cement film from said sieve to a felt transport belt, (iii) applying a mist of a hydrophobizing agent to said at least one fiber cement film, and (iv) accumulating the fiber cement film on an accumulator roll via the felt transport belt, so as to form a hydrophobized fiber cement product. The present invention further relates to various uses of the fiber cement sheets obtainable by the processes of the invention in the building industry.

Abstract: The present invention is directed to a catheter balloon of a balloon catheter comprising a coating consisting of or containing at least one fatty acid, oil or fat and sirolimus as well as to the use of these systems and compositions. Optionally a stent is crimped on such a coated catheter balloon. Further, methods for coating the inventive catheter balloons are described.

Abstract: The present invention relates to balloon catheter coated with an active agent and a shellac alkali salt, preferably shellac ammonium salt. Moreover the present invention relates to a method for coating catheter balloons with a pharmacological active agent and an aqueous solution of shellac.

Abstract: The present invention is directed to valvuloplasty catheter balloons and balloon catheters for valvuloplasty with such catheter balloons coated with at least one layer containing at least one antiproliferative, immunosuppressive, anti-angiogenic, anti-inflammatory, anti-restenotic and/or anti-thrombotic agent and a top coat consisting of a polyvinyl alcohol-polyethylene glycol graft copolymer as well as the use of these balloon catheters for the prevention of restenosis after valvuloplasty.

Abstract: The present invention is directed to a catheter balloon of a balloon catheter comprising a coating consisting of or containing at least one fatty acid, oil or fat and sirolimus as well as to the use of these systems and compositions. Optionally a stent is crimped on such a coated catheter balloon. Further, methods for coating the inventive catheter balloons are described.

Abstract: The present invention is directed to catheter balloons and balloon catheters with such catheter balloons coated with at least one layer containing at least one antiproliferative, immunosuppressive, anti-angiogenic, anti-inflammatory, anti-restenotic and/or anti-thrombotic agent and a top coat consisting of a polyvinyl alcohol—polyethylene glycol graft copolymer as well as the use of these balloon catheters for the prevention of restenosis.

Abstract: A safety guard assembly for use on a handheld power saw is disclosed. The assembly includes a safety guard, a locking mechanism, and a weight. The safety guard is swingably mounted on the hood of the saw. The locking mechanism allows the guard to be swung to an open position and locked in position. In a kick-back situation, the locking mechanism quickly releases. The weight forces the guard to swing rapidly down over the guard, thereby providing protection from the saw blade.

Abstract: The present invention is directed to a radially expandable vessel support having a multitude of annular elements flexibly connected to each other, defining a vascular support with a proximal and a distal end and a longitudinal axis. The annular elements are arranged side by side transversely to the longitudinal axis of the vascular support and connected to each other by means of bending elements. At least two marginally standing annular elements each are linked among each other by a pair of dumbbell shaped bending elements and centrally standing annular elements are linked among each other and to marginally standing annular elements by two S-shaped bending elements each, with at least the centrally standing annular elements being of a zigzag-shaped configuration.

Abstract: The present invention relates to a method for coating catheter balloons with the pharmacological agent paclitaxel and the biological and biodegradable polymer composition shellac and optionally further components. Moreover the present invention relates to paclitaxel and shellac coated catheter balloons obtained according to the coating methods disclosed herein as well as the use of such coated catheter balloons for the short time release of the pharmaceutically active agent paclitaxel for prophylaxis and treatment of restenosis especially restenosis caused by angioplasty. The coated catheter balloons can be used alone or in combination with a coated or uncoated stent crimped on the catheter balloon before or after the coating with shellac and paclitaxel.

Abstract: The invention relates to a radially expandable vessel support which comprises a multitude of zigzag shaped annular elements (2, 3), interconnected in a flexible way by bending elements. Said annular elements define a vessel support (1) with a proximal and a distal end and a longitudinal axis, where the zigzag shaped annular elements (2, 3) are arranged side by side across the longitudinal axis of the vessel support (1), where zigzag shaped annual elements (2, 3) are linked to at least one further annual element by means of at least one bending element which is comprised either of a pair of S-shaped bars (20, 21) or of a pair of bow shaped bars (4, 5) which are located diametrically on the circumference and whose apertures show into opposite directions.

Abstract: A safety guard assembly for use on a handheld power saw is disclosed. The assembly includes a safety guard, a locking mechanism, and a weight. The safety guard is swingably mounted on the hood of the saw. The locking mechanism allows the guard to be swung to an open position and locked in position. In a kick-back situation, the locking mechanism quickly releases. The weight forces the guard to swing rapidly down over the guard, thereby providing protection from the saw blade.

Abstract: Embodiments herein relate to a special form of a bioresorbable metal stent with controlled resorption due to a wrap with a special polymer, thereby ensuring a controlled resorption of the wrapped endoprosthesis subsequent to its implantation into a blood vessel. The resorbable implant comprises a magnesium alloy provided with a biodegradable coating. The biodegradable coating comprises biodegradable polymers and can further include at least one pharmacologically active substance such as an antiproliferative, antimigrative, antiangiogenic, antiinflammatory, antiphlogistic, cytostatic, cytotoxic and/or antithrombotic agent, anti-restenosis agents, corticoids, sex hormones, statins, epothilones, prostacyclins and/or inductors of angiogenesis.

Abstract: The invention relates to a method for loading structured surfaces that are preferably made of a polymer material with the pharmacological agent paclitaxel as well as the coated medical products obtained by means of said method.